Incidence of MGUS and Estimation of Duration Before Recognition

submitted by: WentzMR
Dr. Terry Therneau, a Professor of Biostatistics at Mayo Clinic in Rochester, MN, discusses his article appearing online first and in the November 2012 issue of Mayo Clinic Proceedings, placing the surprising outcome among the statistics discovered in the study into perspective. Available at: S0025-6196(12)00634-9/fulltext

Incidence of MGUS & Estimation of Duration Before First Clinical Recognition

submitted by: WentzMR

Dr. Robert Kyle, professor of medicine, laboratory medicine and pathology, at Mayo Clinic in Rochester, MN, discusses his article appearing online first and in the November 2012 issue of Mayo Clinic Proceedings, where he defines MGUS and explains its role in the development of multiple myeloma and other blood disorders.
Available at:

Fatty acid patterns and risk of prostate cancer in a case-control study nested within the European Prospective Investigation into Cancer and Nutrition

submitted by: ccdahm
Background: Fatty acids in blood may be related to the risk of prostate cancer, but epidemiologic evidence is inconsistent. Blood fatty acids are correlated through shared food sources and common endogenous desaturation and elongation pathways. Studies of individual fatty acids cannot take this into account, but pattern analysis can. Treelet transform (TT) is a novel method that uses data correlation structures to derive sparse factors that explain variation. Objective: The objective...
Authors: Christina Dahm

Advanced Care Planning (ACP) – communicating end of life choices in advance

submitted by: mdanderson
Download from iTunes: . Advanced care planning is not about giving up, emphasizes Katherine Pisters, M.D., professor in Palliative Care and Rehabilitation Medicine, and Donna Zhukovsky, M.D., professor in Thoracic/Head and Neck Medical Oncology, both at MD Anderson Cancer Center. Rather, it’s a way for cancer patients to tell their loved ones what’s important to them as they approach the end of life. MD...

Computational Approaches to Nanosafety and Nanomedicine

submitted by: UP Los Baños
2nd Focus Lecture by Dr. Eduardo R. Mendoza, Visiting Scientist, Department of Membrane Chemistry, Max Planck Institute of Biochemistry, Germany and Senior Research Scientist, Faculty of Physics & Center for NanoScience, Ludwig Maximilian University, Munich, Germany. The lecture covered: (1) Understanding nanoparticle-cell interactions for nanosafety and nanomedicine, (2) A basic model of gold nanoparticles-cell interactions, (3) modelling targeted drug delivery with functionalized...

The history of fluorescence microscopy

submitted by: LUMC_PA_MD
This video shows the history of fluorescence microscopy through the eyes of the eighty-two year Professor Johan Sebastiaan Ploem . Let him tell you about the nature and background of his inventions and his place in the history of microscopy. The current version is in Dutch, an English undertitled version will follow shortley. Deze video toont de geschiedenis van de fluorescentie microscopie door de ogen van de 82 jarige professor Johan Sebastiaan Ploem . Laat hem vertellen over de...